Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MicroDose Mammography Reduces Radiation Dose by Half

By HospiMedica International staff writers
Posted on 18 May 2011
Women in the United States will now have the same opportunity as million of European women already have, to undergo mammography with considerably lower radiation dose. More...


This is the result of the US Food and Drug Administration's (FDA) clearance of the Swedish information technology (IT) and medical technology company Sectra's digital mammography system, Sectra (Linköping, Sweden) MicroDose mammography. Achieving best-in-class cancer detection, the Sectra MicroDose photon counting technology reduces the radiation dose by half of that used by other digital or film-based systems.

"The advantages of a yearly mammography examination clearly outweigh the risks. But a woman undergoing regular mammography examinations is exposed to radiation every time she is screened, and so it is important to minimize radiation dose," said Stamatia Destounis, MD, managing partner, Elizabeth Wende Breast Care, LLC (Rochester, NY, USA).

Sectra MicroDose has already been contributing to a significant reduction of radiation dose in most major European mammography screening programs. It has been used for more than seven years and is operational in countries throughout Europe, Australia, New Zealand, and Japan. Recently, the system was also approved in Canada and Russia.

"Until now, digital mammography systems in the US have managed to reduce the radiation dose slightly below those of film-based systems," stated Dr. Jesper Söderqvist, president of Sectra's mammography operations. "Sectra MicroDose enables mammography service providers to reduce the radiation dose by half, which is a significant benefit to women," added Dr. Söderqvist.

Key to the very high image quality at significantly reduced radiation dose is Sectra's innovative photon counting detector technology. Sectra MicroDose is the first imaging modality based on a photon counting detector technology to receive FDA clearance.

"Ongoing research shows great promise for further improvements in breast cancer detection with our unique photon counting technology," explained Dr. Söderqvist. "Our technology is also the cornerstone in a large European research project for developing and evaluating new revolutionary breast cancer detection methods."

Unlike conventional analog and digital mammography modalities that require a higher dose of radiation to ensure image quality, Sectra MicroDose mammography detects X-ray photons individually. Therefore, the Sectra MicroDose detector makes it possible to reduce the radiation dose by half from that used by other digital or film-based systems, while still obtaining as high or higher image quality. Images are delivered with 25 megapixels, which is two to four times higher resolution than that of other digital systems. The high resolution of the images aids detection of early alterations that occur with breast cancer.

Related Links:

Sectra



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.